Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples